Singapore markets closed

MicroStrategy Incorporated (MSTR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
244.02-1.30 (-0.53%)
As of 10:58AM EST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 2.86B
Enterprise value 5.24B
Trailing P/E 3.72k
Forward P/E 68.97
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)5.50
Price/book (mrq)N/A
Enterprise value/revenue 10.46
Enterprise value/EBITDA -14.22

Trading information

Stock price history

Beta (5Y monthly) 2.22
52-week change 3-27.62%
S&P500 52-week change 3-8.38%
52-week high 3522.80
52-week low 3132.56
50-day moving average 3187.45
200-day moving average 3237.64

Share statistics

Avg vol (3-month) 3687.15k
Avg vol (10-day) 3710.77k
Shares outstanding 59.57M
Implied shares outstanding 6N/A
Float 89.34M
% held by insiders 10.08%
% held by institutions 170.98%
Shares short (12 Jan 2023) 43.49M
Short ratio (12 Jan 2023) 45.91
Short % of float (12 Jan 2023) 442.35%
Short % of shares outstanding (12 Jan 2023) 430.22%
Shares short (prior month 14 Dec 2022) 43.39M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 330 Jul 2002

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022


Profit margin -261.38%
Operating margin (ttm)3.14%

Management effectiveness

Return on assets (ttm)0.36%
Return on equity (ttm)-1,003.82%

Income statement

Revenue (ttm)501.22M
Revenue per share (ttm)44.97
Quarterly revenue growth (yoy)-2.10%
Gross profit (ttm)418.85M
Net income avi to common (ttm)-1.31B
Diluted EPS (ttm)-53.33
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)60.39M
Total cash per share (mrq)5.34
Total debt (mrq)2.45B
Total debt/equity (mrq)N/A
Current ratio (mrq)0.78
Book value per share (mrq)-17.70

Cash flow statement

Operating cash flow (ttm)24.66M
Levered free cash flow (ttm)-753.47M